William Blair Starts Genmab A/S (GMAB) at Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
Go back to William Blair Starts Genmab A/S (GMAB) at Market Perform
November 14, 2022 2:46 AM EST
JPMorgan analyst James Gordon raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK3,450.00 (from DKK2,900.00) while maintaining a Overweight rating.... More
November 14, 2022 2:27 AM EST
Deutsche Bank analyst Emmanuel Papadakis downgraded Genmab A/S (GEN:DC) (NASDAQ: GMAB) from Buy to Hold with a price target of DKK3,100.00.
...
More
November 11, 2022 2:06 PM EST
Deutsche Bank analyst Emmanuel Papadakis downgraded Genmab A/S (GEN:DC) (NASDAQ: GMAB) from Buy to Hold with a price target of DKK3,100.00.
...
More
November 11, 2022 7:22 AM EST
BMO Capital analyst Etzer Darout raised the price target on Genmab A/S (NASDAQ: GMAB) to $37.00 (from $36.00) while maintaining a Market Perform rating.... More
November 10, 2022 10:25 AM EST
Bernstein analyst Wimal Kapadia raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK3,150.00 (from DKK3,000.00) while maintaining a Outperform rating.... More
November 10, 2022 3:03 AM EST
Credit Suisse analyst Dominic Lunn reiterated a Neutral rating and DKK2,800.00 price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB).
...
More
November 10, 2022 2:55 AM EST
Barclays analyst Emily Field raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK3,300.00 (from DKK3,000.00) while maintaining a Overweight rating.... More
